Evaluation of a Bone Marrow Dysmyelopoiesis Immunophenotypic Index for the Diagnosis and Prognosis of Myelodysplastic Syndromes

By  

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders), Vol. 15, Iss. 2, 2015-08 ,pp. : 148-161

Bentham Science Publishers

Access to resources Recommend Favorite

Biologic Characteristics of Bone Marrow Mesenchymal Stem Cells in Myelodysplastic Syndromes

By  

Current Stem Cell Research & Therapy, Vol. 6, Iss. 2, 2011-06 ,pp. : 122-130

Bentham Science Publishers

Access to resources Recommend Favorite

Pathophysiology and management of thrombocytopenia in bone marrow failure: possible clinical applications of TPO receptor agonists in aplastic anemia and myelodysplastic syndromes

By Townsley Danielle   Desmond Ronan   Dunbar Cynthia   Young Neal  

International Journal of Hematology, Vol. 98, Iss. 1, 2013-07 ,pp. : 48-55

Springer Publishing Company

Access to resources Recommend Favorite

The implication of identifying JAK2 V617F in myeloproliferative neoplasms and myelodysplastic syndromes with bone marrow fibrosis

By Olsen Randall  

Journal of Hematopathology, Vol. 1, Iss. 2, 2008-09 ,pp. : 111-117

Springer Publishing Company

Access to resources Recommend Favorite

Increased apoptosis of bone marrow cells and preserved proliferative capacity of selected progenitors predict for clinical response to anti-inflammatory therapy in myelodysplastic syndromes

By Novitzky N.   Mohamed R.   Finlayson J.   du Toit C.  

Experimental Hematology, Vol. 28, Iss. 8, 2000-08 ,pp. : 941-949

Elsevier

Access to resources Recommend Favorite